Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re applying this...
It’s a problem with an enormous impact on patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been misdiagnosed or, even...
Despite incredible advances in the availability of real-world data (RWD) and AI applications, many tech-savvy brand...
In the quest to improve patient outcomes, life sciences companies are increasing their focus on optimizing the patient...
Pharma manufacturers work relentlessly to create drugs and therapies to address some of the most complex health conditions people face. There are years of research and...
Innovate4Outcomes® was born in 2020 as a design-thinking event in response to COVID-19, but it quickly became clear the COVID-19 health crisis could be a catalyst for a...
In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas...
In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...
In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is...
When it comes to multiple sclerosis (MS), there are multiple challenges that can deter patients from receiving the care they...
An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that affects less...
